J 2019

Use of epidemiological analyses in development of colorectal cancer clinical practice guidelines in the Czech Republic

KLUGAROVÁ, Jitka, Miloslav KLUGAR, Jan MUŽÍK, Jiří JARKOVSKÝ, Radim LÍČENÍK et. al.

Basic information

Original name

Use of epidemiological analyses in development of colorectal cancer clinical practice guidelines in the Czech Republic

Authors

KLUGAROVÁ, Jitka (203 Czech Republic, belonging to the institution), Miloslav KLUGAR (203 Czech Republic, guarantor, belonging to the institution), Jan MUŽÍK (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution), Radim LÍČENÍK (203 Czech Republic, belonging to the institution), Petra BÚŘILOVÁ (203 Czech Republic, belonging to the institution), Dana DOLANOVÁ (703 Slovakia, belonging to the institution), Martin HUNČOVSKÝ (203 Czech Republic), Ladislav DUŠEK (203 Czech Republic, belonging to the institution), Ivana SVOBODOVÁ (203 Czech Republic, belonging to the institution), Denisa KREJČÍ (203 Czech Republic, belonging to the institution) and Andrea POKORNÁ (203 Czech Republic, belonging to the institution)

Edition

International Journal of Evidence-Based Healthcare, Wolters Kluwer/Lippincott Williams & Wilkins, 2019, 1744-1609

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30230 Other clinical medicine subjects

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 1.930

RIV identification code

RIV/00216224:14110/19:00110125

Organization unit

Faculty of Medicine

UT WoS

000511111600018

Keywords in English

clinical practice guidelines; colorectal cancer; death; diagnoses; epidemiology; survival; treatment

Tags

International impact, Reviewed
Změněno: 11/5/2020 09:28, Mgr. Tereza Miškechová

Abstract

V originále

Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the fourth most common cause of cancer death worldwide. Crucial in CRC as well as for other effective diagnostics and treatment is the knowledge translation and implementation of the current best available evidence into clinical practice and public health. Clinical practice guidelines are one of the useful tools to be able to improve diagnostics and increase survival rate. The epidemiological analysis was performed based on the data of the Czech National Cancer Registry from 1977 to 2017. We have analysed incidence, prevalence, mortality and primary treatment of CRC in the Czech Republic. The incidence of CRC increased significantly from 1982 to 2002 and is higher in men compared with women based on the data from the National Health Information System in the Czech Republic. The majority of the patients with CRC were diagnosed in early stages. Women were diagnosed at slightly higher age than men. An increase in surgical therapy performed in primary treatment of early CRC was reported from 2006 to 2016. Relative time of survival increased in reported patients with CRC. This analysis reported significant changes in incidence of CRC in the last 40 years as well as in diagnostics and primary therapy in early stages of CRC in the last 12 years. The first ever evidence-based clinical practice guideline on diagnostics and therapy of early CRC in the Czech Republic was developed and disseminated.